• SD Biotechnologies revised its reverse stock split timetable due to a delay in holding an extraordinary shareholders’ meeting.
• The meeting date was moved to Oct. 15, 2026 from Oct. 8, 2026.
• New shares will take effect Nov. 17, 2026; trading will be halted Nov. 13–Dec. 2, 2026; relisting is set for Dec. 3, 2026.
• The reverse split keeps par value at KRW 1,000 from KRW 200; common shares outstanding will drop to 21,946,628 from 109,733,141.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923900286), on September 23, 2026, and is solely responsible for the information contained therein.